C12N 2720/12311
Rotavirus
Official title: Rotavirus, e.g. rotavirus A
C12N2720/12311 (Rotavirus) appears on 220 US grants and 221 published applications in this corpus.
Search patents in C12N- Granted patents
- 220
- Published applications
- 221
- Assignees
- 175
- Inventors
- 555
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 3 | 0 |
| 1994 | 3 | 0 |
| 1995 | 5 | 0 |
| 1996 | 2 | 0 |
| 1997 | 11 | 0 |
| 1998 | 12 | 0 |
| 1999 | 11 | 0 |
| 2000 | 13 | 0 |
| 2001 | 7 | 0 |
| 2002 | 2 | 10 |
| 2003 | 7 | 14 |
| 2004 | 6 | 10 |
| 2005 | 3 | 10 |
| 2006 | 4 | 7 |
| 2007 | 3 | 3 |
| 2008 | 3 | 11 |
| 2009 | 6 | 7 |
| 2010 | 4 | 13 |
| 2011 | 3 | 7 |
| 2012 | 5 | 6 |
| 2013 | 5 | 11 |
| 2014 | 6 | 5 |
| 2015 | 2 | 7 |
| 2016 | 5 | 10 |
| 2017 | 7 | 13 |
| 2018 | 13 | 10 |
| 2019 | 11 | 12 |
| 2020 | 10 | 7 |
| 2021 | 6 | 11 |
| 2022 | 8 | 12 |
| 2023 | 4 | 6 |
| 2024 | 6 | 8 |
| 2025 | 5 | 6 |
| 2026 | 4 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2720/12334Use of virus or viral component as vaccineIndexing code140
- C12N 2720/12322New viral proteins or individual genes, new structural or functional aspects ofIndexing code97
- C12N 2720/12351Methods of production or purification of viral materialIndexing code34
- C12N 2720/12321Viruses as suchIndexing code23
- C12N 2720/12361Methods of inactivation or attenuationIndexing code16
- C12N 2720/12323Virus like particles [vlp]Indexing code9
- C12N 2720/12332Use of virus as therapeutic agent, other than vaccineIndexing code4
- C12N 2720/12341Use of virus, viral particle or viral elements as a vectorIndexing code3
Recent patents
- PCR method for the detection of equine rotavirus group B (ERVB) in biological samples7 Jul 2026US 12,674,212 B2University of Kentucky Research Foundation
- Combined norovirus and rotavirus vaccine composition and methods of preparation31 Mar 2026US 12,589,144 B2Bharat Biotech International Limited
- Recombinant expression platform, constructs and methods for expression of difficult to express proteins (DTE-PS)24 Feb 2026US 12,559,761 B2Premas Biotech Pvt Ltd
- Adjuvant compositions13 Jan 2026US 12,521,433 B2Zoetis Services LLC
- Rotavirus vaccines3 Jun 2025US 12,318,444 B2Cure Vac SE
- Trigger-inducible mrna circularization23 Jul 2026US 2026/0209789 A1Westlake University
- Vp4-based trivalent pseudovirus nanoparticle vaccine for rotavirus and methods of using same9 Jul 2026US 2026/0191949 A1Children's Hospital Medical Center
- Rotavirus b virus-like-particle compostions and antibody assays11 Jun 2026US 2026/0158131 A1University of Kentucky Research Foundation
- Genetically modified vero cells16 Apr 2026US 2026/0103682 A1Washington University
- Rotavirus vaccines1 Jan 2026US 2026/0000749 A1CureVac AG
Most cited
By later US patents
- Oral vaccines118US 4,920,209 AAmerican Home Products Corporation · 1990
- Recombinant flagellin vaccines92US 6,130,082 AAmerican Cyanamid Company · 2000
- Production of orthomyxoviruses in monkey kidney cells using protein-free media88US 6,146,873 ABaxter Aktiengesellschaft · 2000
- Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence86US 5,223,424 APrutech Research And Development · 1993
- Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system81US 5,891,676 ABaylor College of Medicine · 1999